The Ministry of Health is seeking feedback to some proposed material to be incorporated by reference to the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, which prescribes the minimum quality standard for cannabis-based ingredients and medicinal cannabis products.
Read more about the consultation in the Gazette notice:
Read the Gazette notice outlining the proposed changes (and how you can access these resources) can be found.
Due to copyright restrictions, we are not able to display a copy online or send you an electronic copy of the European Pharmacopoeia, the United States Pharmacopoeia-National Formulary, or the British Pharmacopoeia.
You can purchase these publications through the following links:
- The European Pharmacopoeia (version 11.0 including supplement 11.3)
- The United States Pharmacopoeia-National Formulary (2023 Issue 1)
- The British Pharmacopoeia 2023
If you have any comment on the proposal to incorporate the specified material by reference, please email [email protected] by Friday 8 September 2023.
